Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group

P. García Alfonso,A. Muñoz Martin,M. Mendez Urena,R Quiben-Pereira,E. González Flores,G. Pérez-Manga

Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group

2009

P. García Alfonso
A. Muñoz Martin
M. Mendez Urena
R Quiben-Pereira
E. González Flores
G. Pérez-Manga

Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group

Keywords:

Capecitabine
Fluorouracil
Phases of clinical research
Pathology
Medicine
Colorectal cancer
Cancer
XELIRI
Irinotecan
Chemotherapy
Regimen
Standard treatment
combination chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations